{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:39:46Z","timestamp":1789634386674,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasma B-type natriuretic peptide (BNP) is a useful marker for diagnosis of hemodynamically significant PDA (hsPDA) and serial BNP measurement is also valuable for monitoring treatment response. This retrospective study was performed to evaluate whether plasma BNP level can predict treatment response to ibuprofen in preterm infants born at &lt;30 weeks of gestation with hsPDA. Plasma BNP was measured before (baseline) and 12 to 24\u2009h after (post-treatment) completion of the first (IBU1) and second (IBU2) course of ibuprofen. We compared the BNP levels of responders (closed or insignificant PDA) with those of non-responders (hsPDA requiring further pharmacologic or surgical closure) to\u00a0each course of ibuprofen. The treatment response rates for IBU1 (n\u2009=\u200992) and IBU2 (n\u2009=\u200919) were 74% and 26%, respectively. In IBU1, non-responders had lower gestational age and birth weight than responders (both, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), while in IBU2, non-responders had lower birth weight (<jats:italic>P<\/jats:italic>\u2009=\u20090.014) and platelet counts (<jats:italic>P<\/jats:italic>\u2009=\u20090.005) than responders; however, baseline BNP levels did not differ significantly between responders and non-responders in either IBU1 (median 1,434 vs. 1,750\u2009pg\/mL) or IBU2 (415 vs. 596\u2009pg\/mL). Post-treatment BNP was a useful marker for monitoring treatment efficacy of IBU1 and IBU2 for hsPDA with a cut-off value of 331\u2009pg\/mL (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 423\u2009pg\/mL(<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.010), respectively. We did not identify a cut-off baseline BNP level that could predict treatment response to ibuprofen in preterm infants with hsPDA.<\/jats:p>","DOI":"10.1038\/s41598-020-61291-w","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T11:03:11Z","timestamp":1583838191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus"],"prefix":"10.1038","volume":"10","author":[{"given":"Seong Hee","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1347-4200","authenticated-orcid":false,"given":"Byong Sop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euiseok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Yeon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jeong","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Ai-Rhan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"61291_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1542\/peds.104.6.1345","volume":"104","author":"DD Marshall","year":"1999","unstructured":"Marshall, D. D. et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics. 104, 1345\u20131350 (1999).","journal-title":"Pediatrics."},{"key":"61291_CR2","doi-asserted-by":"crossref","unstructured":"Hermes-DeSantis, E. R. & Clyman, R. I. Patent ductus arteriosus: pathophysiology and management. J. Perinatol. 26 Suppl 1, S14\u20138; discussion S22\u201313 (2006).","DOI":"10.1038\/sj.jp.7211465"},{"key":"61291_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mpd.2000.106569","volume":"137","author":"M Kluckow","year":"2000","unstructured":"Kluckow, M. & Evans, N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J. Pediatr. 137, 68\u201372 (2000).","journal-title":"J. Pediatr."},{"key":"61291_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12519-015-0059-6","volume":"12","author":"U Kessler","year":"2016","unstructured":"Kessler, U. et al. Outcome in neonates with necrotizing enterocolitis and patent ductus arteriosus. World J. Pediatr. 12, 55\u201359 (2016).","journal-title":"World J. Pediatr."},{"key":"61291_CR5","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1542\/peds.2008-2232","volume":"124","author":"J Richards","year":"2009","unstructured":"Richards, J., Johnson, A., Fox, G. & Campbell, M. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics. 124, e287\u2013293 (2009).","journal-title":"Pediatrics."},{"key":"61291_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00431-012-1805-6","volume":"171","author":"NM van der Lugt","year":"2012","unstructured":"van der Lugt, N. M. et al. Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus. Eur. J. Pediatr. 171, 1673\u20131677 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"61291_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00431-002-0915-y","volume":"161","author":"P Lago","year":"2002","unstructured":"Lago, P. et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur. J. Pediatr. 161, 202\u2013207 (2002).","journal-title":"Eur. J. Pediatr."},{"key":"61291_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6904-11-8","volume":"11","author":"A Kushnir","year":"2011","unstructured":"Kushnir, A. & Pinheiro, J. M. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. BMC Clin. Pharmacol. 11, 8 (2011).","journal-title":"BMC Clin. Pharmacol."},{"key":"61291_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pedneo.2015.04.017","volume":"58","author":"H Olgun","year":"2017","unstructured":"Olgun, H. et al. Repeated courses of oral ibuprofen in premature infants with patent ductus arteriosus: efficacy and safety. Pediatr. Neonatol. 58, 29\u201335 (2017).","journal-title":"Pediatr. Neonatol."},{"key":"61291_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00246-007-9166-z","volume":"29","author":"M Sangem","year":"2008","unstructured":"Sangem, M., Asthana, S. & Amin, S. Multiple courses of indomethacin and neonatal outcomes in premature infants. Pediatr. Cardiol. 29, 878\u2013884 (2008).","journal-title":"Pediatr. Cardiol."},{"key":"61291_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jpeds.2010.05.020","volume":"157","author":"ES Kim","year":"2010","unstructured":"Kim, E. S. et al. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants. J. Pediatr. 157, 745\u2013750.e1 (2010).","journal-title":"J. Pediatr."},{"key":"61291_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/jp.2015.33","volume":"35","author":"MF Ahamed","year":"2015","unstructured":"Ahamed, M. F. et al. Predictors of successful closure of patent ductus arteriosus with indomethacin. J. Perinatol. 35, 729\u2013734 (2015).","journal-title":"J. Perinatol."},{"key":"61291_CR13","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1111\/apa.12814","volume":"104","author":"M Steiner","year":"2015","unstructured":"Steiner, M. et al. Preterm infants who later require duct ligation show different vital signs and pH in early postnatal life. Acta Paediatr. 104, e7\u2013e13 (2015).","journal-title":"Acta Paediatr."},{"key":"61291_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cca.2007.12.020","volume":"390","author":"M Cantinotti","year":"2008","unstructured":"Cantinotti, M., Clerico, A., Murzi, M., Vittorini, S. & Emdin, M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin. Chim. Acta. 390, 12\u201322 (2008).","journal-title":"Clin. Chim. Acta."},{"key":"61291_CR15","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1542\/peds.2004-1837","volume":"115","author":"BM Choi","year":"2005","unstructured":"Choi, B. M. et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics. 115, e255\u2013261 (2005).","journal-title":"Pediatrics."},{"key":"61291_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2005.03.040","volume":"147","author":"PA Flynn","year":"2005","unstructured":"Flynn, P. A., da Graca, R. L., Auld, P. A., Nesin, M. & Kleinman, C. S. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J. Pediatr. 147, 38\u201342 (2005).","journal-title":"J. Pediatr."},{"key":"61291_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000343034","volume":"103","author":"JH Lee","year":"2013","unstructured":"Lee, J. H. et al. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants? Neonatology. 103, 118\u2013122 (2013).","journal-title":"Neonatology."},{"key":"61291_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2009.12.045","volume":"157","author":"JH Hsu","year":"2010","unstructured":"Hsu, J. H. et al. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J. Pediatr. 157, 79\u201384 (2010).","journal-title":"J. Pediatr."},{"key":"61291_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.jp.7211383","volume":"25","author":"S Sanjeev","year":"2005","unstructured":"Sanjeev, S. et al. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J. Perinatol. 25, 709\u2013713 (2005).","journal-title":"J. Perinatol."},{"key":"61291_CR20","first-page":"131","volume":"41","author":"VK Kalra","year":"2011","unstructured":"Kalra, V. K. et al. Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus. Ann. Clin. Lab. Sci. 41, 131\u2013137 (2011).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"61291_CR21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0022-3476(95)70172-9","volume":"127","author":"M Kluckow","year":"1995","unstructured":"Kluckow, M. & Evans, N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J. Pediatr. 127, 774\u2013779 (1995).","journal-title":"J. Pediatr."},{"key":"61291_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00431-009-0983-3","volume":"168","author":"A Sehgal","year":"2009","unstructured":"Sehgal, A. & McNamara, P. J. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur. J. Pediatr. 168, 907\u2013914 (2009).","journal-title":"Eur. J. Pediatr."},{"key":"61291_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1067\/S0022-3476(03)00303-2","volume":"143","author":"K Itabashi","year":"2003","unstructured":"Itabashi, K., Ohno, T. & Nishida, H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J. Pediatr. 143, 203\u2013207 (2003).","journal-title":"J. Pediatr."},{"key":"61291_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.earlhumdev.2017.07.011","volume":"113","author":"NS Boghossian","year":"2017","unstructured":"Boghossian, N. S. et al. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants. Early Hum. Dev. 113, 10\u201317 (2017).","journal-title":"Early Hum. Dev."},{"key":"61291_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00246-018-1831-x","volume":"39","author":"Y Hu","year":"2018","unstructured":"Hu, Y., Jin, H., Jiang, Y. & Du, J. Prediction of therapeutic response to cyclooxygenase inhibitors in preterm infants with patent ductus arteriosus. Pediatr. Cardiol. 39, 647\u2013652 (2018).","journal-title":"Pediatr. Cardiol."},{"key":"61291_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3345\/kjp.2016.59.4.183","volume":"59","author":"HA Jeong","year":"2016","unstructured":"Jeong, H. A. et al. Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus. Korean J. Pediatr. 59, 183\u2013189 (2016).","journal-title":"Korean J. Pediatr."},{"key":"61291_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.earlhumdev.2010.06.012","volume":"86","author":"C Pees","year":"2010","unstructured":"Pees, C., Walch, E., Obladen, M. & Koehne, P. Echocardiography predicts closure of patent ductus arteriosus in response to ibuprofen in infants less than 28 week gestational age. Early Hum. Dev. 86, 503\u2013508 (2010).","journal-title":"Early Hum. Dev."},{"key":"61291_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jtcvs.2007.07.027","volume":"135","author":"S Tschuppert","year":"2008","unstructured":"Tschuppert, S. et al. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters. J. Thorac. Cardiovasc. Surg. 135, 78\u201382 (2008).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"61291_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/PCC.0b013e31822882b5","volume":"13","author":"R Desandes","year":"2012","unstructured":"Desandes, R. et al. Echocardiography as a guide for patent ductus arteriosus ibuprofen treatment and efficacy prediction. Pediatr. Crit. Care Med. 13, 324\u2013327 (2012).","journal-title":"Pediatr. Crit. Care Med."},{"key":"61291_CR30","first-page":"715265","volume":"2012","author":"KW Olsson","year":"2012","unstructured":"Olsson, K. W., Jonzon, A. & Sindelar, R. A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22-27 weeks gestational age. Crit. Care Res. Pract. 2012, 715265 (2012).","journal-title":"Crit. Care Res. Pract."},{"key":"61291_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/14767058.2017.1317736","volume":"31","author":"D Louis","year":"2018","unstructured":"Louis, D., Wong, C., Ye, X. Y., McNamara, P. J. & Jain, A. Factors associated with non-response to second course indomethacin for PDA treatment in preterm neonates. J. Matern. Fetal Neonatal Med. 31, 1407\u20131411 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"3 Pt 1","key":"61291_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1542\/peds.112.3.583","volume":"112","author":"RL Keller","year":"2003","unstructured":"Keller, R. L. & Clyman, R. I. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics. 112(3 Pt 1), 583\u2013587 (2003).","journal-title":"Pediatrics."},{"key":"61291_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm0110-33","volume":"16","author":"R Clyman","year":"2010","unstructured":"Clyman, R. & Chemtob, S. Vessel remodeling in the newborn: platelets fill the gap. Nat. Med. 16, 33\u201335 (2010).","journal-title":"Nat. Med."},{"key":"61291_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000431281","volume":"108","author":"SR Simon","year":"2015","unstructured":"Simon, S. R. et al. Platelet counts and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology. 108, 143\u2013151 (2015).","journal-title":"Neonatology."},{"key":"61291_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/14767058.2016.1163684","volume":"30","author":"S Mitra","year":"2017","unstructured":"Mitra, S., Chan, A. K. & Paes, B. A. The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 30, 127\u2013133 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"61291_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fped.2018.00041","volume":"6","author":"H Sallmon","year":"2018","unstructured":"Sallmon, H. et al. Association between platelet counts before and during pharmacological therapy for patent ductus arteriosus and treatment failure in preterm infants. Front. Pediatr. 6, 41 (2018).","journal-title":"Front. Pediatr."},{"key":"61291_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.siny.2018.03.007","volume":"23","author":"WP de Boode","year":"2018","unstructured":"de Boode, W. P., Kluckow, M., McNamara, P. J. & Gupta, S. Role of neonatologist-performed echocardiography in the assessment and management of patent ductus arteriosus physiology in the newborn. Semin. Fetal Neonatal Med. 23, 292\u2013297 (2018).","journal-title":"Semin. Fetal Neonatal Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61291-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:06:16Z","timestamp":1670313976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61291"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61291-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4430"}}